Valacyclovir study stopped -- worse survival.
James
J S
JS
D017088:AIDS-Related Opportunistic Infections / Q000401:mortality / Q000517:prevention & control*; D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003586:Cytomegalovirus Infections / Q000401:mortality / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004992:Ethics, Medical; D006801:Humans; D010919:Placebos; D016019:Survival Analysis; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*
D010919:Placebos; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir